Science Says
In Our Lifetimes — Transforming Cancer Treatment
What will treatments for cancer and other diseases look like a decade from now? Join us for Science Says, presented by Microsoft, to hear from researchers and physicians about tomorrow’s treatments and tools, which are taking shape today in labs and clinics at Fred Hutchinson Cancer Center and UW Medicine.
Fred Hutch President and Director Thomas J. Lynch, Jr., MD, who holds the Raisbeck Endowed Chair, will lead a fascinating discussion with researchers whose work is changing the way we think about preventing, diagnosing, treating, and surviving cancer. You’ll hear from people who are decoding the genetic origins of cancer, radically rethinking the role of radiation therapy, and developing and testing new drugs that help patients live longer.
We’ll leave plenty time for your questions, so come curious!
Speakers
Thomas J. Lynch Jr., MD
President and Director and Raisbeck Endowed Chair, Fred Hutch
Tom is a world-renowned scientist with expertise in solid tumor research, precision medicine, and fundamental biology. He is also a respected oncologist who has led top U.S. cancer centers for more than three decades. Tom is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.
Min Fang, MD, PhD
Physician and Professor, Clinical Research Division and Director of Clinical Cancer Genomics, Fred Hutch
Professor, Department of Laboratory Medicine and Pathology, UW Medicine
As a specialist in clinical molecular genetics and cytogenetics, Min studies changes in DNA that could potentially lead to cancer and seeks to identify chromosomal abnormalities that can be used to both diagnose cancer early and guide treatment. She is working to dramatically accelerate this process — and increase survival — by partnering with Google to develop an artificial intelligence algorithm that can quickly pinpoint chromosomal issues in patients with acute myeloid leukemia and other blood cancers.
Petros Grivas, MD, PhD
Physician, Professor, and Clinical Director, Genitourinary Cancers Program, Fred Hutch and UW Medicine
Petros, a medical oncologist, cares for patients with genitourinary cancers, such as bladder, prostate, and testicular cancer. He is also an innovator whose clinical research and leadership have contributed to FDA approval of new drugs for patients with urinary tract cancers. During the pandemic, Petros led a large international study to identify factors linked to severe COVID-19 and death in patients with cancer, casting light on the urgent need to eliminate racial disparities in cancer care.
Ramesh Rengan, MD, PhD
Physician and Professor, Fred Hutch
Peter Wooten Professor and Chair of the Department of Radiation Oncology, UW Medicine
As a physician-researcher, Ramesh focuses on caring for patients with lung cancer and melanoma and advancing innovations to increase the benefits and decrease the harms from radiation treatment. He is exploring how altering the particle, dose, and rate of radiation delivery can selectively eradicate a tumor while preserving healthy tissue. He is also focused on using radiation to trigger an anti-cancer immune response, effectively forcing the cancer to behave as a vaccine against itself.